RCMI Coordinating Center (RCMI CC) Header Logo

Weifan Zheng

TitleAssociate Professor
Faculty RankAssociate Professor
InstitutionNorth Carolina Central University
AddressBiomanufacturing Research Institute and Technology Enterprise
Durham NC 27707
vCardDownload vCard

    Collapse Affiliation 

    Collapse Research 
    Collapse research activities and funding
    SC3GM086265     (ZHENG, WEIFAN)Jan 1, 2009 - Dec 31, 2013
    Integrated Cheminformatics Resource for Orphan Neurodegenerative Diseases
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dong X, Zheng W. Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAs. Molecules. 2022 Sep 28; 27(19). PMID: 36234948.
      Citations:    Fields:    
    2. Ji X, Jin C, Dong X, Dixon MS, Williams KP, Zheng W. Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer. Molecules. 2020 Aug 28; 25(17). PMID: 32872166.
      Citations: 3     Fields:    Translation:Humans
    3. Niture S, Gyamfi MA, Lin M, Chimeh U, Dong X, Zheng W, Moore J, Kumar D. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation. Cell Death Dis. 2020 03 09; 11(3):178. PMID: 32152268.
      Citations: 13     Fields:    Translation:HumansAnimals
    4. Niture S, Dong X, Arthur E, Chimeh U, Niture SS, Zheng W, Kumar D. Oncogenic Role of Tumor Necrosis Factor a-Induced Protein 8 (TNFAIP8). Cells. 2018 12 24; 8(1). PMID: 30586922.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    5. Law CJ, Ashcroft HA, Zheng W, Sexton JZ. Assay development and multivariate scoring for high-content discovery of chemoprotectants of endoplasmic-reticulum-stress-mediated amylin-induced cytotoxicity in pancreatic beta cells. Assay Drug Dev Technol. 2014 Sep; 12(7):375-84. PMID: 25181410.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    6. Dong X, Ebalunode JO, Yang SY, Zheng W. Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling. Curr Comput Aided Drug Des. 2011 Sep 01; 7(3):181-9. PMID: 21726192.
      Citations: 6     Fields:    Translation:HumansAnimals
    7. Dong X, Hilliard SG, Zheng W. Structure-based quantitative structure--activity relationship modeling of estrogen receptor ?-ligands. Future Med Chem. 2011 Jun; 3(8):933-45. PMID: 21707397.
      Citations: 1     Fields:    Translation:HumansCells
    8. Ebalunode JO, Jagun C, Zheng W. Informatics approach to the rational design of siRNA libraries. Methods Mol Biol. 2011; 672:341-58. PMID: 20838976.
      Citations: 3     Fields:    
    9. Ebalunode JO, Zheng W. Cheminformatics Approach to Gene Silencing: Z Descriptors of Nucleotides and SVM Regression Afford Predictive Models for siRNA Potency. Mol Inform. 2010 Dec 17; 29(12):871-81. PMID: 27464351.
      Citations: 1     Fields:    
    10. Dong X, Ebalunode JO, Cho SJ, Zheng W. A novel structure-based multimode QSAR method affords predictive models for phosphodiesterase inhibitors. J Chem Inf Model. 2010 Feb 22; 50(2):240-50. PMID: 20095527.
      Citations:    Fields:    
    11. Ebalunode JO, Zheng W. Molecular shape technologies in drug discovery: methods and applications. Curr Top Med Chem. 2010; 10(6):669-79. PMID: 20337591.
      Citations: 5     Fields:    
    12. Adekoya A, Dong X, Ebalunode J, Zheng W. Development of improved models for phosphodiesterase-4 inhibitors with a multi-conformational structure-based QSAR method. Curr Chem Genomics. 2009 Dec 31; 3:54-61. PMID: 20161837.
    13. Ebalunode JO, Zheng W. Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments. J Chem Inf Model. 2009 Jun; 49(6):1313-20. PMID: 19480404.
      Citations: 3     Fields:    Translation:HumansCells
    14. Ebalunode JO, Dong X, Ouyang Z, Liang J, Eckenhoff RG, Zheng W. Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds. Bioorg Med Chem. 2009 Jul 15; 17(14):5133-8. PMID: 19520579.
      Citations: 2     Fields:    Translation:AnimalsCells
    15. Ebalunode JO, Ouyang Z, Liang J, Zheng W. Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. J Chem Inf Model. 2008 Apr; 48(4):889-901. PMID: 18396858.
      Citations: 12     Fields:    Translation:Cells
    Zheng's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (83)
    Co-Authors (5)
    Similar People (60)
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support